Manish R Sharma
6PUBLICATIONS
87CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Mar 30, 2026
Telisotuzumab Adizutecan (ABBV-400), a Novel c-Met-Targeting Antibody-Drug Conjugate: First-in-Human Results in Advanced Gastric/Gastroesophageal Junction Cancer.John H Strickler, Judith Raimbourg, Jonathan E Cohen
|Feb 22, 2026
Phase 1 Study of INBRX-105, a TNFRSF9 (4-1BB) and PD-L1 Bispecific Antibody, in Patients with Select Solid Tumors.Jong Chul Park, David Berz, Manish R Sharma
|Jan 27, 2026
Phase 1 Study of INBRX-105, a TNFRSF9 (4-1BB) and PD-L1 Bispecific Antibody, in Patients With Select Solid Tumors.Jong Chul Park, David Berz, Manish R Sharma
|Dec 14, 2023
Cobimetinib Plus Vemurafenib in Patients With Solid Tumors With BRAF Mutations: Results From the Targeted Agent and Profiling Utilization Registry Study.Funda Meric-Bernstam, Michael Rothe, Pam K Mangat
|Jun 03, 2023
SHP2 Inhibition Sensitizes Diverse Oncogene-Addicted Solid Tumors to Re-treatment with Targeted Therapy.Alexander Drilon, Manish R Sharma, Melissa L Johnson
Pageof 1
Frequent Collaborators
2 joint publications
Anthony W Tolcher
2 joint publications
Frank Tsai
2 joint publications
John T Hamm
2 joint publications
Ralph J Hauke
2 joint publications
Naomi B Haas
2 joint publications
Jyoti Malhotra
2 joint publications
Rachel E Sanborn
2 joint publications
Justin A Call
2 joint publications
David Berz
2 joint publications
Jong Chul Park
